VAS
ONC

Vestmark Advisory Solutions’s BeOne Medicines Ltd ONC Stock Holding History

Vestmark Advisory Solutions’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857K Buy
3,006
+1,226
+69% +$361K 0.01% 1008
2026
Q1 		$529K Sell
1,780
-31
-2% -$10K 0.01% 1050
2025
Q4 		$550K Sell
1,811
-43
-2% -$14.1K 0.01% 970
2025
Q3 		$632K Buy
1,854
+15
+0.8% +$4.55K 0.01% 642
2025
Q2 		$445K Sell
1,839
-1,499
-45% -$368K 0.01% 639
2025
Q1 		$909K Buy
3,338
+1,686
+102% +$394K 0.02% 409
2024
Q4 		$305K Buy
1,652
+4
+0.2% +$817 0.01% 489
2024
Q3 		$370K Sell
1,648
-1,357
-45% -$244K 0.01% 419
2024
Q2 		$429K Sell
3,005
-84
-3% -$12.9K 0.02% 418
2024
Q1 		$483K Buy
3,089
+1,488
+93% +$240K 0.02% 393
2023
Q4 		$289K Buy
1,601
+139
+10% +$25.1K 0.01% 423
2023
Q3 		$263K Sell
1,462
-1,840
-56% -$364K 0.02% 357
2023
Q2 		$589K Sell
3,302
-61
-2% -$14K 0.02% 562
2023
Q1 		$725K Sell
3,363
-45
-1% -$10.8K 0.03% 511
2022
Q4 		$750K Buy
3,408
+1,350
+66% +$248K 0.04% 489
2022
Q3 		$277K Sell
2,058
-976
-32% -$168K 0.02% 689
2022
Q2 		$491K Buy
3,034
+1,335
+79% +$209K 0.03% 542
2022
Q1 		$320K Buy
1,699
+362
+27% +$77K 0.02% 700
2021
Q4 		$362K Sell
1,337
-36
-3% -$12.2K 0.02% 646
2021
Q3 		$498K Buy
1,373
+82
+6% +$26.8K 0.03% 491
2021
Q2 		$443K Buy
1,291
+98
+8% +$32.5K 0.03% 512
2021
Q1 		$415K Buy
1,193
+412
+53% +$136K 0.04% 498
2020
Q4 		$202K Buy
781
+70
+10% +$19.3K 0.02% 583
2020
Q3 		$204K Buy
+711
New +$167K 0.03% 525

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vestmark Advisory Solutions's ONC Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its BeOne Medicines Ltd (ONC) stake by 69% in Q2 2026, buying an estimated $361K and bringing the position to 3,006 shares worth $857K. The position accounts for 0.01% of the portfolio, ranked #1008.

Vestmark Advisory Solutions first reported a position in ONC in Q3 2020 and has held it in 24 quarters since. The position peaked at $909K in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Vestmark Advisory Solutions held 3,006 shares of BeOne Medicines Ltd worth $857K as of Q2 2026.
  • Vestmark Advisory Solutions bought 1,226 BeOne Medicines Ltd shares in Q2 2026, an estimated $361K.
  • BeOne Medicines Ltd made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #1008 holding.
  • Vestmark Advisory Solutions first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 24 quarters since.
  • Vestmark Advisory Solutions's BeOne Medicines Ltd position peaked at $909K in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.